It can be difficult to know when a baby or dementia patient is suffering from persistent pain because either he can not communicate his level of suffering or not.
But a breakthrough test that identifies chronic pain using color biomarkers
The world's first test, the so-called painHS test, was developed by a team of Australian scientists after chronic pain in immune cells has a different color than normal acute pain.
The test is able to distinguish between the colors of the blood pain with the help of light measuring instruments and to immediately detect those in chronic pain.
"We literally quantify the color of the pain," said neuroscientist Professor Mark Hutchinson will reveal the test at a meeting of the Department of Pain Medicine in Sydney on Sunday.
One in five people in Australia suffers from chronic pain.
Prof. Hutchinson believes that this test will be a cost-effective way for physicians to pinpoint the severity of chronic pain in patients with back problems, cancer and migraine
Those who are unable to describe their pain as very young children and those with dementia will especially benefit, he says.
"Self-reporting (by patients) will still be key, but what this does is that those forgotten people who are unable to convey their pain conditions such as babies or people with dementia can now have their condition diagnosed and diagnosed treated, "he said.
It also has the potential to revolutionize the treatment of pain for animals, said Prof. Hutchinson.
"Animals can not tell us if they're in pain, but here's a Dr. Doolittle test that allows us to" talk "to the animals, so we can find out if they're in pain and then we can help them, "he said.
It is to be hoped that the painHS test will be ready for further use by physicians and GPs within 1